NASA probe gets close-up views of large hurricane on Saturn

Apr. 30, 2013 NASA's Cassini spacecraft has provided scientists the first close-up, visible-light views of a behemoth hurricane swirling around Saturn's north pole.

In high-resolution pictures and video, scientists see the hurricane's eye is about 1,250 miles (2,000 kilometers) wide, 20 times larger than the average hurricane eye on Earth. Thin, bright clouds at the outer edge of the hurricane are traveling 330 mph(150 meters per second). The hurricane swirls inside a large, mysterious, six-sided weather pattern known as the hexagon.

"We did a double take when we saw this vortex because it looks so much like a hurricane on Earth," said Andrew Ingersoll, a Cassini imaging team member at the California Institute of Technology in Pasadena. "But there it is at Saturn, on a much larger scale, and it is somehow getting by on the small amounts of water vapor in Saturn's hydrogen atmosphere."

Scientists will be studying the hurricane to gain insight into hurricanes on Earth, which feed off warm ocean water. Although there is no body of water close to these clouds high in Saturn's atmosphere, learning how these Saturnian storms use water vapor could tell scientists more about how terrestrial hurricanes are generated and sustained.

Both a terrestrial hurricane and Saturn's north polar vortex have a central eye with no clouds or very low clouds. Other similar features include high clouds forming an eye wall, other high clouds spiraling around the eye, and a counter-clockwise spin in the northern hemisphere.

A major difference between the hurricanes is that the one on Saturn is much bigger than its counterparts on Earth and spins surprisingly fast. At Saturn, the wind in the eye wall blows more than four times faster than hurricane-force winds on Earth. Unlike terrestrial hurricanes, which tend to move, the Saturnian hurricane is locked onto the planet's north pole. On Earth, hurricanes tend to drift northward because of the forces acting on the fast swirls of wind as the planet rotates. The one on Saturn does not drift and is already as far north as it can be.

"The polar hurricane has nowhere else to go, and that's likely why it's stuck at the pole," said Kunio Sayanagi, a Cassini imaging team associate at Hampton University in Hampton, Va.

Scientists believe the massive storm has been churning for years. When Cassini arrived in the Saturn system in 2004, Saturn's north pole was dark because the planet was in the middle of its north polar winter. During that time, the Cassini spacecraft's composite infrared spectrometer and visual and infrared mapping spectrometer detected a great vortex, but a visible-light view had to wait for the passing of the equinox in August 2009. Only then did sunlight begin flooding Saturn's northern hemisphere. The view required a change in the angle of Cassini's orbits around Saturn so the spacecraft could see the poles.

"Such a stunning and mesmerizing view of the hurricane-like storm at the north pole is only possible because Cassini is on a sportier course, with orbits tilted to loop the spacecraft above and below Saturn's equatorial plane," said Scott Edgington, Cassini deputy project scientist at NASA's Jet Propulsion Laboratory in Pasadena, Calif. "You cannot see the polar regions very well from an equatorial orbit. Observing the planet from different vantage points reveals more about the cloud layers that cover the entirety of the planet."

Cassini changes its orbital inclination for such an observing campaign only once every few years. Because the spacecraft uses flybys of Saturn's moon Titan to change the angle of its orbit, the inclined trajectories require attentive oversight from navigators. The path requires careful planning years in advance and sticking very precisely to the planned itinerary to ensure enough propellant is available for the spacecraft to reach future planned orbits and encounters.

Go here to see the original:

NASA probe gets close-up views of large hurricane on Saturn

Wow! Monster Hurricane on Saturn Spied by NASA Spacecraft

Spectacular new images from a NASA spacecraft orbiting Saturn have captured the most detailed views ever of an enormous hurricane churning around the ringed planet's north pole.

The stunning new images and video of the Saturn hurricane, whichwere taken by NASA's Cassini probe, show that the storm's eye is 1,250 miles (2,000 kilometers) wide about 20 times bigger than typical hurricane eyes on Earth. And the Saturn maelstrom is more powerful than its Earth counterparts, with winds at its outer edge whipping around at 330 mph (530 km/h).

"We did a double take when we saw this vortex because it looks so much like a hurricane on Earth," Cassini imaging team member Andrew Ingersoll, of Caltech in Pasadena, said in a statement. "But there it is at Saturn, on a much larger scale, and it is somehow getting by on the small amounts of water vapor in Saturn's hydrogen atmosphere." [Amazing Views of Saturn's Mysterious Hurricane (Photos)]

Saturn's hurricane swirls inside a mysterious, six-sided vortex. Unlike hurricanes on Earth, which tend to drift northward as our planet rotates, the Saturn storm and its hexagonal vortex have been camped out at the north pole for a while.

"The polar hurricane has nowhere else to go, and that's likely why it's stuck at the pole," Kunio Sayanagi, a Cassini imaging team associate at Hampton University in Hampton, Va., said in a statement.

While the Saturn hurricane is larger and more powerful than Earth hurricanes, storms on the two planets are alike in some ways. For example, both have central eyes containing very low clouds or no clouds at all, researchers said. Other shared traits are high clouds forming the eye wall, and a counterclockwise spin in the northern hemisphere.

So scientists plan to study how the Saturn storm feeds off atmospheric water vapor, in the hopes of gaining insight into hurricanes here on Earth (which gain their strength from warm ocean water).

Cassini's instruments detected the Saturn storm shortly after the probe arrived in orbit around the ringed planet in 2004. The hurricane was in darkness at the time, however, because it was the middle of the northern Saturn winter.

So Cassini had to wait for the onset of the northern spring in August 2009 to get a good look at the hurricane in visible light. The detailed new views required a shift in the spacecraft's orbit as well, achieved using flybys of Saturn's huge moon Titan, researchers said.

"Such a stunning and mesmerizing view of the hurricane-like storm at the north pole is only possible because Cassini is on a sportier course, with orbits tilted to loop the spacecraft above and below Saturn's equatorial plane," said Scott Edgington, Cassini deputy project scientist at NASA's Jet Propulsion Laboratory in Pasadena.

Link:

Wow! Monster Hurricane on Saturn Spied by NASA Spacecraft

Mars Rover Opportunity Slips Into Standby Mode, NASA Says

NASA's long-lived Opportunity Mars rover has gone into a self-imposed standby mode on the Red Planet, the robot's handlers say.

Mission controllers for Opportunity, which landed on Mars in January 2004, first learned of the issue on Saturday (April 27). On that day, the rover got back in touch after a nearly three-week communication moratorium caused by an unfavorable planetary alignment called a Mars solar conjunction, in which Mars and Earth are on opposite sides of the sun.

The Opportunity rover apparently put itself into standby on April 22 after sensing a problem during a routine camera check, mission managers said.

"Our current suspicion is that Opportunity rebooted its flight software, possibly while the cameras on the mast were imaging the sun," Opportunity project manager John Callas, of NASA's Jet Propulsion Laboratory in Pasadena, Calif., explained in a statement Monday (April 29).

"We found the rover in a standby state called automode, in which it maintains power balance and communication schedules, but waits for instructions from the ground," Callas added. "We crafted our solar conjunction plan to be resilient to this kind of rover reset, if it were to occur."

Opportunity's handlers prepared new commands Monday designed to spur the rover into resuming operations, mission team members said.

The golf-cart-size Opportunity landed on Mars more than nine years ago along with its twin, Spirit, on a three-month mission to search for signs of past water activity on the Red Planet. The two rovers found plenty of such evidence, and then kept trundling across Mars. Spirit was declared dead in 2010, but Opportunity is still going strong.

Mars solar conjunctions occur every 26 months, so Opportunity's team knows how to weather them. This most recent conjunction, in fact, is the fifth that the rover has endured.

Mars solar conjunctions affect NASA's entire fleet of robotic Red Planet explorers. Mission controllers resumed sending commands to the agency's venerable Mars Odyssey orbiter Monday and plan to do the same with the Mars rover Curiosity on Wednesday (May 1), officials said.

Follow Mike Wall on Twitter@michaeldwallandGoogle+.Follow us @Spacedotcom, Facebook or Google+. Originally published onSPACE.com.

Read the rest here:

Mars Rover Opportunity Slips Into Standby Mode, NASA Says

NASA Captures Monster Hurricane

Apr 30, 2013 12:26pm

(NASA/JPL-Caltech/SSI)

Usually, hurricanes on Earth have a small eye and much larger outer bands. But incredibly on Saturn 1,250 miles is the distance of the center eye only. The entire storm could be several thousand miles more.

As for the wind speed in the storm, usually in hurricanes the strongest wind is in the center of the storm around what is called the eye wall of the hurricane, and tends to get weaker as you get to the edge of the hurricane. The wind speed on the outer edge of the cloud band of Saturns hurricane is 330 mph and the winds in the center eye are four times faster than some of the strongest hurricanes on Earth. To compare Saturns storm to hurricanes that affected the U.S., the strongest hurricane to hit the U.S. was Camille in 1969 with winds of 190 mph.

One of the interesting facts is that usual hurricanes on Earth feed off the water vapor from the warm ocean water. That gives it the needed energy for the hurricane to develop. But on Saturn there is no body of water nearby for this storm to feed off. Instead it is feeding off of small amounts of water vapor in Saturns hydrogen atmosphere.

Another interesting fact: Hurricanes on Earth form usually in the tropical latitudes and move north due to the forces acting on them. But Saturns storm is located at the planets north pole that has made it stationary with nowhere further north to go. Because of this discovery, NASA scientists believe that it could have been there for years.

Only in 2009 sun began reaching the northern Hemisphere allowing Cassini spacecraft to capture these images. This is because Saturns seasons last nine years each, therefore their north pole is dark nine years at a time. So when the space craft first reached Saturn in 2004, the north pole was in the middle of winter.

NASA scientists will study this terrestrial hurricane-like storm because even though there are differences in size, strength and source of energy, it does carry similar characteristics such a central eye that has no clouds, counter clockwise spin in the northern Hemisphere, and high clouds circling the eye.

Visit link:

NASA Captures Monster Hurricane

NASA Captures Monster Hurricane from Space

Saturn Hurricane

NASA's spacecraft Cassini took this amazing colorful picture of a Saturn storm that resembles a hurricane on Earth. The center eye of the storm on Saturn is about 1,250 miles wide. That's 20 times larger than the average hurricane eye on Earth, that's the distance between Dallas and Washington, DC.

Usually, hurricanes on Earth have a small eye and much larger outer bands. But incredibly on Saturn 1,250 miles is the distance of the center eye only. The entire storm could be several thousand miles more.

As for the wind speed in the storm, usually in hurricanes the strongest wind is in the center of the storm around what is called "the eye wall" of the hurricane, and tends to get weaker as you get to the edge of the hurricane. The wind speed on the outer edge of the cloud band of Saturn's hurricane is 330 mph and the winds in the center eye are four times faster than some of the strongest hurricanes on Earth. To compare Saturn's storm to hurricanes that affected the U.S., the strongest hurricane to hit the U.S. was Camille in 1969 with winds of 190 mph.

One of the interesting facts is that usual hurricanes on Earth feed off the water vapor from the warm ocean water. That gives it the needed energy for the hurricane to develop. But on Saturn there is no body of water nearby for this storm to feed off. Instead it is feeding off of small amounts of water vapor in Saturn's hydrogen atmosphere.

Another interesting fact: Hurricanes on Earth form usually in the tropical latitudes and move north due to the forces acting on them. But Saturn's storm is located at the planet's north pole that has made it stationary with nowhere further north to go. Because of this discovery, NASA scientists believe that it could have been there for years.

Only in 2009 sun began reaching the northern Hemisphere allowing Cassini spacecraft to capture these images. This is because Saturn's seasons last nine years each, therefore their north pole is dark nine years at a time. So when the space craft first reached Saturn in 2004, the north pole was in the middle of winter.

NASA scientists will study this terrestrial hurricane-like storm because even though there are differences in size, strength and source of energy, it does carry similar characteristics such a central eye that has no clouds, counter clockwise spin in the northern Hemisphere, and high clouds circling the eye.

See the rest here:

NASA Captures Monster Hurricane from Space

Sun Plus Nanotechnology: Can Solar Energy Get Bigger by Thinking Small

Patrick J. Kiger

Nearly 60 years after researchers first demonstrated a way to convert sunlight into energy, science is still grappling with a critical limitation of the solar photovoltaic cell.

It just isn't that efficient at turning the tremendous power of the sun into electricity.

And even though commercial solar cells today have double to four times the 6 percent efficiency of the one first unveiled in 1954 by Bell Laboratories in New Jersey, that hasn't been sufficient to push fossil fuel from its preeminent place in the world energy mix.

But now, alternative energy researchers think that something really smallnanotechnology, the engineering of structures a fraction of the width of a human haircould give a gigantic boost to solar energy. (Related Quiz: "What You Don't Know About Solar Power")

"Advances in nanotechnology will lead to higher efficiencies and lower costs, and these can and likely will be significant," explains Matt Beard, a senior scientist for the U.S. Department of Energy's National Renewable Energy Laboratory (NREL). "In fact, nanotechnology is already having dramatic effects on the science of solar cells."

Of course, the super-expensive solar arrays used in NASA's space program are far more efficient than those installed on rooftops. (Related: "Beam It Down: A Drive to Launch Space-Based Solar") And in the laboratory, scientists have achieved record-breaking efficiencies of more than 40 percent. But such contests are a testament to the gap between solar potential and the mass market cells of today.

The power output of the sun that reaches the Earth could provide as much as 10,000 times more energy than the combined output of all the commercial power plants on the planet, according to the National Academy of Engineering. The problem is how to harvest that energy. Todays commercial solar cells, usually fashioned from silicon, are still relatively expensive to produce (even though prices have come down), and they generally manage to capture only 10 to 20 percent of the sunlight that strikes them. This contributes to the high cost of solar-generated electricity compared to power generated by conventional fossil-fuel-burning plants. By one comparative measure, the U.S. Energy Information Administration estimated the levelized cost of new solar PV as of 2012 was about 56 percent higher than the cost of generation from a conventional coal plant.

Nanotechnology may provide an answer to the efficiency problem, by tinkering with solar power cells at a fundamental level to boost their ability to convert sunlight into power, and by freeing the industry to use less expensive materials. If so, it would fulfill the predictions of some of nanotechnology's pioneers, like the late Nobel physicist Richard Smalley, who saw potential in nanoscale engineering to address the world's energy problems. (See related: "Nano's Big Future") Scientists caution that theres still a lot of work ahead to overcome technical challenges and make these inventions ready for prime time. For example, more research is needed on the environmental, health, and safety aspects of nano-materials, said the National Academy of Sciences in a 2012 report that looked broadly at nanotechnology, not at solar applications in particular. (Related Pictures: "Seven Ingredients for Better Car Batteries.")

But Luke Henley, a University of Illinois at Chicago chemistry professor who received a 2012 National Science Foundation grant to develop a solar-related nanotechnology project, predicts there will be major advances over the next five to ten years. "Its potentially a game changer," he says. Here are five intriguing recent nanotechnology innovations that could help to boost solar power.

Read more:

Sun Plus Nanotechnology: Can Solar Energy Get Bigger by Thinking Small

Nominations Open for the Inaugural Harrington Prize for Innovation in Medicine

CLEVELAND, April 30, 2013 /PRNewswire/ --National and international nominations are being sought for the inaugural Harrington Prize for Innovation in Medicine, which will honor a medical researcher for notable achievements in innovation, creativity, and potential for clinical application.

The Harrington Prize, which carries a $20,000 honorarium, is the result of collaboration between the American Society for Clinical Investigation (ASCI), one of the nation's oldest and most respected medical honor societies, and the Harrington Discovery Institute at University Hospitals Case Medical Center. The Harrington Discovery Institute is a national initiative dedicated to physician-scientists, enabling them to transform breakthrough insights into novel therapies that enhance patient care. Both organizations understand the scientific and administrative hurdles that hinder advancement of discovery into medicines that improve human health, and they are eager to highlight those who have navigated the path successfully.

Deadline for nominations is June 28, 2013. A nomination form can be found at: HarringtonDiscovery.org/ThePrize

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board will review nominations and select the recipient. In addition to the honorarium, the awardee delivers the Harrington Prize Lecture at the 2014 ASCI/AAP Joint Meeting (April 25-27) and publishes a review in the Journal of Clinical Investigation.

For more information about Harrington Prize nominations, ASCI, and the Harrington Discovery Institute, please visit HarringtonDiscovery.org or contact Natalie Haynes, Harrington Discovery Institute Program Manager, at 216-368-1038 or Natalie.Haynes@UHhospitals.org.

About the ASCI

The American Society for Clinical Investigation (ASCI), established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI comprises more than 3,000 physician-scientists from all medical specialties elected to the Society for their outstanding records of scholarly achievement in biomedical research. The ASCI represents active physician-scientists who are at the bedside, at the research bench, and at the blackboard. Many of its members are widely recognized leaders in academic medicine. The ASCI is dedicated to the advancement of research that extends our understanding and improves the treatment of human diseases, and members are committed to mentoring future generations of physician-scientists. The ASCI considers the nominations of several hundred physician-scientists from the United States and abroad each year and elects up to 80 new members each year for their significant research accomplishments.

About University Hospitals

University Hospitals serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians. At the core of our health system is University Hospitals Case Medical Center.The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and clinical research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopaedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. For more information, go to UHhospitals.org.

Read more:

Nominations Open for the Inaugural Harrington Prize for Innovation in Medicine

Penn Medicine Vice Dean Receives Prestigious Translational Science Award for Contributions to Public Health and Policy

Newswise PHILADELPHIA--Brian L. Strom, MD, MPH, the executive vice dean for Institutional Affairs in the Perelman School of Medicine at the University of Pennsylvania and professor of Biostatistics and Epidemiology, was recently presented with a National Award for Career Achievement and Contribution to Clinical and Translational Science at the Translational Science 2013 meeting in Washington, D.C.

Dr. Strom was named a 2013 Career Distinguished Investigator for his outstanding contributions to translational science from clinical use into public benefit and policy. A nationally-recognized leader in clinical research training and clinical epidemiology, Dr. Strom focuses heavily on the field of pharmacoepidemiology, which is the application of epidemiologic methods to study drug use and effects in populations. He is known as a founder of the field of pharmacoepidemiology, and a pioneer in using large automated databases for research.

As one of many specific contributions, his work was also pivotal in getting the American Heart Association and American Dental Association to reverse 50 years of guidelines, and recommend against use of antibiotics to prevent infective endocarditis, instead of recommending for this widespread practice. Since 10 percent of patients have these conditions and the typical patient undergoes dental care twice yearly, this resulted in a large proportion of the population no longer needing frequent antibiotics.

The awards committee for the Translational Science 2013 annual meeting is made up representatives from Association for Clinical and Translational Science and the American Federation for Medical Research (ACTS/AFMR). This is the fourth year ACTS/AFMR has acknowledged distinguished investigators and educators who have had national impact by virtue of contributions to clinical and translational science. Three awards were presented this year, including translation from bench research to patient application and translation from early clinical use to applicability for widespread clinical practice.

In addition to his responsibilities as executive vice dean, Dr. Strom is also the George S. Pepper Professor of Public Health and Preventive Medicine and a professor of Medicine and Pharmacology.

Dr. Strom earned a BS in Molecular Biophysics and Biochemistry from Yale University in 1971, and then an MD from the Johns Hopkins University School of Medicine in 1975. From 1975 to 1978 he was an intern and resident in Internal Medicine, and from 1978 to 1980 he was a National Institutes of Health fellow in Clinical Pharmacology at the University of California, San Francisco. He simultaneously earned an MPH in Epidemiology at the University of California, Berkeley. He has been on the faculty of the University of Pennsylvania School of Medicine since 1980.

He was also the founding Director of the Center for Clinical Epidemiology and Biostatistics (CCEB) and founding Chair of the Department of Biostatistics and Epidemiology. The mission of the CCEB is to improve the health of the public by linking epidemiology, biostatistics, and clinical medicine. The CCEB that he created at Penn includes over 550 faculty, research and support staff, and trainees. CCEB research currently receives nearly $49 million/year in extramural support.

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

Original post:

Penn Medicine Vice Dean Receives Prestigious Translational Science Award for Contributions to Public Health and Policy

NextBio Announces Translational Medicine Partnership with Sanofi

SANTA CLARA, Calif., April 30, 2013 /PRNewswire/ --NextBio today announced a multi-year collaboration with Sanofi (SNY) aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi's drug research and development, as part of Sanofi's Translational Medicine for Patients (TM4P) program.

(Logo: http://photos.prnewswire.com/prnh/20130402/SF86976LOGO)

NextBio will provide Sanofi with the NextBio Clinical platform for aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi clinical trials and Sanofi hospital partners. NextBio's unique data integration platform, user interface and real-time Big Data analytics will allow Sanofi biologists and clinicians to tap into a vast, growing collection of patient data as it becomes available, as a key enabling technology for translational and clinical research.

"Sanofi has long used NextBio as an important component of the company's preclinical research programs," said Saeid Akhtari, President and Chief Executive Officer of NextBio. "The new translational medicine partnership with NextBio, with its Big Data Genomics capabilities, will enable Sanofi to implement patient-centered approaches across all stages of translational and clinical research in several major therapeutic areas, including oncology and diabetes."

About NextBio

NextBio provides a state of the art scientific platform to aggregate and interpret large quantities of molecular and other life sciences data for research and clinical applications. NextBio's platform integrates data from multiple repositories and diverse technologies by means of a unique correlation engine, which pre-computes billions of significant connections between disparate public and proprietary clinical and experimental data. This feature enables interpretation of an individual's molecular data. It also provides translational researchers the ability to look across the clinical and molecular data of entire populations for clinical trial stratification and selection, hypotheses generation, and biomarker discovery. NextBio Clinical, which in 2012 passed an independent HIPAA audit, is designed for seamless integration with existing clinical and research systems. Backed by highly scalable, Big Data technology, it is capable of analyzing petabytes of data. NextBio's platform is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.

Today, NextBio is used by researchers and clinicians in over 50 top commercial and academic institutions including the National Institute of Health, The University of Southern California, Sanford-Burnham Medical Research Institute, Sanofi, Pfizer, Novartis, Celgene, Eli Lilly, Genzyme, Johnson & Johnson, Merck, Regeneron, GlaxoSmithKline, Harvard Medical School, Scripps Research Institute, Stanford University, University of California at Berkeley, Takeda and many others. To learn more about NextBio, please visit our website at http://www.nextbio.com.

More:

NextBio Announces Translational Medicine Partnership with Sanofi

Cooper Clinic Welcomes Robert Beard, MD, to Preventive Medicine Team

DALLAS, TX--(Marketwired - Apr 29, 2013) - Cooper Clinic today announced Dr. Robert Beard, MD has joined Cooper Clinic as a preventive medicine physician, specializing in internal medicine and pediatrics.

"We are delighted to welcome Dr. Beard to the Cooper Clinic team," said Camron Nelson, MD, CEO of Cooper Clinic. "This year marks the 45th anniversary of Dr. Kenneth H. Cooper's first best-seller, Aerobics, which launched a worldwide fitness revolution and recognized him as the pioneer of preventive medicine. Today our team of best-in-class physicians continues to further Dr. Cooper's mission of fitness and preventive medicine, helping people live better both sooner and later."

Dr. Beard will perform comprehensive physical exams for patients. Physical exams can include cardiovascular screening for early signs of heart disease, laboratory analysis including vitamin D and omega-3 testing, skin cancer screening and a nutrition consultation, among other tests. Exams are customized based on age, gender, medical history, specific needs and recommendations from the Cooper Clinic preventive medicine physicians.

"Cooper Clinic is world-renowned as the leader in preventive medicine," said Dr. Beard, Preventive Medicine Physician at Cooper Clinic. "I look forward to spreading the Get Cooperized message and helping my patients make good health a habit."

Dr. Beard was most recently an internal medicine hospitalist at MedProvider InPatient Care Unit in Dallas. He graduated from the University of Texas with a Bachelor of Arts in Psychology and received his Doctor of Medicine from Texas Tech University Health Sciences Center School of Medicine, where he was salutatorian of his class. While completing his internal medicine and pediatrics internship and residency at the University of Arkansas, he served as chief resident. Dr. Beard is certified by the American Board of Internal Medicine and American Board of Pediatrics, and is licensed by the Texas Board of Medical Examiners.

To learn more about Cooper Clinic's comprehensive physical exam please visit cooper-clinic.com.

About Cooper ClinicCooper Clinic, a Cooper Aerobics company based at the world-renowned Cooper Aerobics Center in Dallas, helps patients Get Cooperized by giving them an in-depth picture of their health and an action plan to improve it. A leading preventive medicine facility offering same-day results, Cooper Clinic provides comprehensive physical exams, cardiology, breast health, preventive and cosmetic dermatology, gastroenterology, imaging and nutrition services. Founded in 1970 by preventive medicine pioneer and "father of aerobics" Kenneth H. Cooper, MD, MPH,Cooper Clinic has seen more than 100,000 patients and performed more than 265,000 physical exams. For more information call 866.906.2667 (COOP) or visit cooper-clinic.com.

Visit link:

Cooper Clinic Welcomes Robert Beard, MD, to Preventive Medicine Team

Hong Kong prescribes new dose of old Chinese medicine

Despite the age of its recipes, Chinese medicine -- which continues to thrive among Hong Kong's seven million residents -- is not standing still.

A growing number of young university-trained practitioners are pioneering changes within the industry, providing traditional remedies with modern efficiency.

Sofie Lau may work as a paediatric nurse and she may live in the modern, fast-paced city of Hong Kong -- but when it comes to treating her own ill-health, she prefers ancient remedies.

She pours a pack of brown powder into a glass of hot water, stirs it well and drinks the murky mixture down, hoping the traditional Chinese medicine will cure her feverish cold.

Lau, 25, says it feels more natural to turn to Chinese medicine.

"I've tried Western medicine, but usually I feel very tired after I take it. Even though I can recover very fast, I will become sick again afterwards," she explains at the Chinese medicine centre where she has come for treatment.

"But I can't just sit in front of the stove and watch herbs boiling for eight hours. I'm busy with work, if we had to boil the herbal soup like we did in the past, perhaps I wouldn't consider Chinese medicine as an option."

While Chinese medicine masters used to issue instructions for the tedious hours-long process of mixing, soaking, brewing and distilling herbs, nowadays practitioners prescribe ready-made powders.

The complicated brewing process is even outsourced, with orders made over the Internet for doorstep delivery.

It is the latest development for a practice that is thousands of years old and was traditionally passed down through the generations but was regulated in 1999 as the city eyed becoming a Chinese medicine trading hub.

Read the original:

Hong Kong prescribes new dose of old Chinese medicine

Biobanking For Medicine: Technology And Market 2013-2023

NEW YORK, April 30, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biobanking For Medicine: Technology And Market 2013-2023 http://www.reportlinker.com/p0765582/Biobanking-For-Medicine-Technology-And-Market-2013-2023.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation

Report Details

Biobanks - what are their technological and commercial prospects?

See what the future holds for biobanking in human medicine. Visiongain's updated report gives you its revenue predictions to 2023. There you see sales data, technological trends, opportunities and financial prospects.

Our study shows you the potential of technologies, products and services for that archiving of medical biosamples. In that work you see forecasted sales at overall world market, submarket and national level. Discover what's likely to happen from 2013.

In biobanking, many opportunities remain, especially for pharmaceutical applications. In our work you discover which areas can most develop and prosper. Read on to scan crucial features of that industry, find what drives it, and see what its future market could be worth.

Forecasts and other analyses to help you find the best growth opportunities

In our study you find revenue forecasting to 2023, historical data, growth rates and market shares. There you assess quantitative and qualitative analysis, business news, outlooks and developmental trends. You gain 47 tables, 44 charts and seven full research interviews.

Our work lets you investigate the most promising and lucrative aspects of biorepositories, biotrusts and biolibraries, helping you stay ahead in knowledge. That way, you reduce the risk of your missing out.

Read more:

Biobanking For Medicine: Technology And Market 2013-2023

Modernizing Medicine Leverages Nuance Technology to Make It Easier for Doctors to Document Patient Visits Through Speech

BOCA RATON, FL--(Marketwired - Apr 30, 2013) - Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based, specialty-specific electronic medical records (EMR) system, announced today that it is integrating Nuance's speech recognition technology within EMA, which can help improve physician documentation productivity, enhance physician satisfaction and assist physicians in keeping clinical information accurate and up to date in patient records.

Leveraging speech recognition software by Nuance, Modernizing Medicine's customers can reap the productivity and financial benefits of talking naturally and at their own pace to document patient visits within EMA, while using built-in voice navigation, and correction capabilities and mobile device gesture support within the software.

"EMA was built to save physicians time, and Modernizing Medicine wants busy doctors to utilize EMA's iPad app even more efficiently by speaking their documentation, saving them the time it takes to type," said Charles Brodsky, Executive Vice President of Business Development at Modernizing Medicine.

Benefits of using EMA with speech recognition:

For more information about EMA, now with speech recognition, visit http://www.modmed.com/speech-to-text.

About Modernizing MedicineModernizing Medicine is delivering the next generation of electronic medical records (EMR) technology for the healthcare industry. Our product, Electronic Medical Assistant (EMA), is a cloud-based, specialty-specific EMR with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry, orthopedics, plastic surgery and cosmetic markets, and to more than 800 physician practices across the country.In 2013 Modernizing Medicine was listed at No. 47 on FORBES annual ranking of America's Most Promising Companies.

The rest is here:

Modernizing Medicine Leverages Nuance Technology to Make It Easier for Doctors to Document Patient Visits Through Speech

10 Most Selective Medical Schools

The U.S. News Short List, separate from our overall rankings, is a regular series that magnifies individual data points in hopes of providing students and parents a way to find which undergraduate or graduate programs excel or have room to grow in specific areas. Be sure to explore The Short List: College and The Short List: Grad School to find data that matters to you in your college or grad school search.

Med schools may be on a mission to increase enrollment, but that doesn't mean they're accepting just anyone. In fact, some medical schools are being even more selective.

At George Washington University's School of Medicine and Health Sciences, only 2.1 percent of fall 2012 applicants were offered admission, down from 3.1 percent in fall 2010. This drop could be caused by a spike in applicants, which jumped by more than 4,100 between 2010 and 2012, according to data reported by the school.

The D.C.-based med school is not alone in its selectivity. The average acceptance rate at U.S. medical programs for fall 2012 was only 8.3 percent, according to data reported by 114 ranked medical schools in an annual U.S. News survey.

[Learn why most med school applications are rejected.]

That rate drops to an average of 3.3 percent at the 10 pickiest institutions, making getting into the most selective programs akin to winning the med school lottery.

Mayo Medical School in Minnesota, which tied George Washington with a 2.1 percent acceptance rate, is the only school on the list that isn't located on the coasts. Three California med schools -- Stanford University School of Medicine, University of California--San Francisco and the David Geffen School of Medicine at UCLA -- represented the West Coast.

[Find out which med schools receive the most applications.]

East Coast schools include top-ranked Harvard Medical School in Massachusetts, as well as the Columbia University College of Physicians and Surgeons in New York and the School of Medicine at Wake Forest University in North Carolina. Schools designated by U.S. News as Unranked were excluded from this list. U.S. News did not calculate a numerical ranking for Unranked programs because the program did not meet certain criteria that U.S. News requires to be numerically ranked.

Below are the 10 medical schools with the lowest acceptance rates for fall 2012.

More here:

10 Most Selective Medical Schools

Statement from the University of Sydney Medical School

The University of Sydney Medical School condemns the retrieval of executed prisoners' organs for transplantation in China and endorses the Declaration of Istanbul on Organ Trafficking and Transplant Tourism that was signed in 2008.

It is our outright opposition to the retrieval of executed prisoners' organs for transplantation that has cemented our support for our Honorary Professor Huang Jiefu, who separate to his credentials as a transplantation surgeon has more importantly been a leading agent for change in China to its organ transplant system.

Huang Jiefu is recognised internationally for having made significant changes to the regulation of China's organ transplantation processes in an effort to curb the practice of organ retrieval from executed prisoners.

Huang was appointed an honorary professor in 2008 in recognition of his significant achievements in improving the Chinese health system and his ongoing involvement with the University of Sydney. His appointment was renewed in 2011 and he remains a valued contributor to the research and educational collaborations between the Medical School and our colleagues in China.

He has been an outspoken critic of organ retrieval from executed prisoners since 2005.

Huang is credited with seeking to eliminate China's reliance on organ retrieval from executed prisoners including by:

In February this year Huang Jiefu again publicly asserted that less reliance on executed prisoners would be necessary for reform of the organ transplantation system in China.

On 12 March the State Council of the People's Republic of China announced that the position of Vice-Minister of Health, held by Huang Jiefu, would be eliminated in the latest institutional restructuring plan. He has since been appointed as the Director of the Organ Transplantation Committee of the Chinese Government and remains influential in driving reform of organ transplantation in China and the international community.

The President of the Transplantation Society, which represents the entire international transplant community, has expressed the highest professional regard for Huang Jiefu. Professor Francis L Delmonico has described Huang as the foremost leader in China for progressive change in organ donation and transplantation.

The University of Sydney Medical School supports Huang's commitment to reform of the Chinese transplantation system and his continued association with the University as one of its honorary professors.

Read the original post:

Statement from the University of Sydney Medical School

Raspberry Pi


Raspberry Pi WebSphere Liberty Profile controlled car
Video of a remote controlled car where the radio receiver has been replaced with a raspberry pi and a PWM controller board. The Car has its own WiFi network ...

By: WASdev

See the rest here:

Raspberry Pi

Liberty in Books: The Financial Crisis and the Free Market Cure with John Allison – Video


Liberty in Books: The Financial Crisis and the Free Market Cure with John Allison
The primary cause for the 2008-09 financial crisis, and for our ongoing economic woes, is government policy. Financial services is the most regulated industr...

By: feeseminars

Excerpt from:

Liberty in Books: The Financial Crisis and the Free Market Cure with John Allison - Video